10.5680/lhuii000037
Medical treatment for urogenital tuberculosis (UGTB)
Wejse, Christian
Christian
Wejse
Department of Infectious Diseases/Center for Global Health, Dept of Public Health; Aarhus University, Aarhus University Hospital; Denmark
GMS
2018
Book chapter
610 Medical sciences; Medicine
Urology
2018-08-09
Urogenital tuberculosis (UGTB) should in general be treated as pulmonary TB with a four-drug regimen of Isoniazid, Rifampicin, Ethambutol and Pyrazinamide for a total of 6 months, Ethambutol and Pyrazinamide only the first two months. Some patients may need longer treatment (cavitary disease, kidney abscess/malfunction, HIV co-infection). Treatment of multi-drug resistant tuberculosis (MDR-TB) requires use of long-term intravenous treatment with aminoglycosides and other drugs with considerable toxicity for 18–24 months. Complications such as urinary tract obstruction may occur and should be treated with corticosteroids or surgery.
en
licensed under the Creative Commons Attribution 4.0 license